Summary
Webinar Link
This webinar will explore the evolving landscape of neoadjuvant and adjuvant treatment for lung cancer. Oncologists and surgeon experts will highlight the latest data, including immunotherapy and targeted mutation strategies from ASCO and WCLC, and examine how these advances impact surgical decision-making, techniques, and patient outcomes. A live discussion will address key controversies, including the role of radiation and adjuvant therapy choices.
Supported by AstraZeneca
Moderator
Joseph Shrager, MD
Stanford University
Palo Alto, CA
Panelists
Kiran H. Lagisetty, MD
University of Michigan
Ann Arbor, MI
Joel Neal, MD, PhD
Stanford University
Palo Alto, CA